SB1860 HFLR Page 1
BOLD FACE denotes Committee Amendments. 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
HOUSE OF REPRESENTATIVES - FLOOR VERSION
STATE OF OKLAHOMA
2nd Session of the 58th Legislature (2022)
ENGROSSED SENATE
BILL NO. 1860 By: McCortney, Taylor, Bullard,
Burns, Garvin, Stanley,
Pemberton, Standridge,
Stephens, Rader, Coleman,
Pederson, Simpson, Kidd,
Murdock, Jech, Leewright,
and Rogers of the Senate
and
McEntire, Olsen, Hasenbeck,
Pae, and Grego of the House
An Act relating to the Patient’s Right to Pharmacy
Choice Act; amending 36 O.S. 2021, Sections 6960,
6961, 6962, and 6963, which relate to definitions,
retail pharmacy network access standards, compliance
review, and health insurer monitoring; defining
terms; modifying definition; expanding retail
pharmacy network access standards; prohibiting
pharmacy benefits managers fro m requiring patient use
affiliated pharmacy; providing for expansion of
pharmacy network participation; prohibitin g provider
contracts from limiting the ability of a pharmacy to
disclose certain health car e and cost informatio n;
providing health insurers perform ing pharmacy
benefits management activities be responsible for
certain conduct; modifyin g patient choices of in-
network pharmacy; providing that pharmacy benefits
managers not require or incentivize individuals
through certain means; construing provision;
repealing 36 O.S. 2021, Section 6964, which relates
to Pharmacy and Therapeutics Committee s; updating
statutory reference; and providing an effective date.
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKL AHOMA:
SB1860 HFLR Page 2
BOLD FACE denotes Committee Amendments. 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
SECTION 1. AMENDATORY 36 O.S. 2021, Section 6960, is
amended to read as follows:
Section 6960. For purposes of the Patient ’s Right to Pharmacy
Choice Act:
1. “Health insurer” means any corporation, association, benefit
society, exchange, partn ership or individual licensed by the
Oklahoma Insurance Code;
2. “Mail-order pharmacy” means a pharmacy licensed by this
state that primarily dispenses and delivers covered drugs via common
carrier;
3. “Pharmacy benefits management” means any or all of t he
following activities:
a. provider contract negotiation and/or provider network
administration including decisions related to provider
network participation status,
b. drug rebate contract negoti ation or drug rebate
administration, and
c. claims processing which may include claim billing and
payment services;
4. “Pharmacy benefits manager ” or “PBM” means a person or
entity that performs pharmacy benefits management activities and any
other person or entity acting for such a person or entity performing
pharmacy benefits management activities. under a contractual or
employment relationship in the performance of pharmacy benefits
SB1860 HFLR Page 3
BOLD FACE denotes Committee Amendments. 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
management for a managed -care company, nonprofit hospital, medical
service organization, insurance company, third-party payor or a
health program administered by a department of this state
Notwithstanding any other provision within the Patient’s Right to
Pharmacy Choice Act, a self-funded plan administered by an employe r
or organized labor union who negotiates and executes all provi der
contracts directly with a pharmacy or the pharmacy’s contracted
pharmacy services administrative organization, and a pharmacy
provider who does not use a pharmacy services administrative
organization shall not be deemed a pharmacy benefits manager of its
own group health plan and shall not be restricted in its ability to
design and manage its own group health plan ;
4. “Pharmacy and therapeutics committee ” or “P&T committee”
means a committee at a ho spital or a health insurance plan that
decides which drugs will appear on that entity’s drug formulary;
5. “Retail pharmacy” or “provider” means a pharmacy, as defined
in Section 353.1 of Title 59 of the Oklahoma Statutes , licensed by
the State Board of P harmacy or an agent or representative of a
pharmacy;
5. 6. “Retail pharmacy network” means retail pharmacy providers
contracted with a PBM in which the pharmacy primarily fills and
sells prescriptions via a retail, storefront location;
SB1860 HFLR Page 4
BOLD FACE denotes Committee Amendments. 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
6. 7. “Rural service area” means a five-digit ZIP code in whic h
the population density is less than one thousand (1,000) individuals
per square mile;
8. “Specialty drug” means prescription medication that requires
special handling, administration, or monit oring and is used for the
treatment of patients with serious health conditions requiring
complex therapies. Specialty drugs shall also include drugs that
are limited in distribution by the manu facturer and may be purchased
only at specialty pharmacies;
7. 9. “Suburban service area” means a five-digit ZIP code in
which the population density is between one thousand (1,000) and
three thousand (3,000) individuals per sq uare mile; and
8. 10. “Urban service area” means a five-digit ZIP code in
which the population density is greater than three thousand (3,000)
individuals per square mile.
SECTION 2. AMENDATORY 36 O.S. 2021, Section 6961, is
amended to read as follows:
Section 6961. A. Pharmacy be nefits managers (PBMs) shall
comply with the following r etail pharmacy network access standards:
1. At least ninety percent (90%) of covered individuals
residing in an each urban service area live within t wo (2) miles of
a retail pharmacy participating in the PBM’s retail pharmacy
network;
SB1860 HFLR Page 5
BOLD FACE denotes Committee Amendments. 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
2. At least ninety percent (90%) of covered individuals
residing in an each urban service area live within five (5) miles of
a retail pharmacy designated as a preferred participating pharmacy
in the PBM’s retail pharmacy network;
3. At least ninety percent (90%) of covered individuals
residing in a each suburban service area l ive within five (5) miles
of a retail pharmacy participating in the PBM’s retail pharmacy
network;
4. At least ninety perc ent (90%) of covered individuals
residing in a each suburban service area live within seven (7) miles
of a retail pharmacy designated as a preferred participating
pharmacy in the PBM’s retail pharmacy network;
5. At least seventy percent (70%) of covered individuals
residing in a each rural service area live within fifteen (15) mile s
of a retail pharmacy participating in the PBM ’s retail pharmacy
network; and
6. At least seventy percent (70%) of covered individuals
residing in a each rural service area li ve within eighteen (18)
miles of a retail pharmacy designated as a preferred pa rticipating
pharmacy in the PBM’s retail pharmacy netw ork.
B. Mail-order pharmacies shall not be used to meet access
standards for retail pharmacy ne tworks.
C. Pharmacy benefits managers shall not r equire patients to use
pharmacies that are directly or i ndirectly owned by the or
SB1860 HFLR Page 6
BOLD FACE denotes Committee Amendments. 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
affiliated with a pharmacy benefits manager, including all regular
prescriptions, refills or specialty drugs regardless of d ay supply.
D. Pharmacy benefits managers shall no t in any manner on any
material, including but not limit ed to mail and ID cards, include
the name of any pharm acy, hospital or other providers unless it
specifically lists all pharmacies, hospitals and prov iders
participating in the preferred and nonprefer red pharmacy and health
networks.
SECTION 3. AMENDATORY 36 O.S. 2021, Section 6962, is
amended to read as follows:
Section 6962. A. The Oklahoma Insurance Department shall
review and approve retail pharmacy net work access for all pharmacy
benefits managers (PBMs) to ensure compliance with Section 4 of this
act 6961 of this title.
B. A PBM, or an agent of a PBM, shall not:
1. Cause or knowingly permit the use of advertisement,
promotion, solicitation, represent ation, proposal or o ffer that is
untrue, deceptive or misleading;
2. Charge a pharmacist or pharmacy a fee related to the
adjudication of a claim, including without limitation a fee for:
a. the submission of a claim,
b. enrollment or participation in a re tail pharmacy
network, or
SB1860 HFLR Page 7
BOLD FACE denotes Committee Amendments. 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
c. the development or management of claims proces sing
services or claims payment services related to
participation in a retail pharmacy network;
3. Reimburse a pharmacy or pharmacist in the state an amount
less than the amount th at the PBM reimburse s a pharmacy owned by or
under common ownership with a PBM for providing the same covered
services. The reimb ursement amount paid to the pharmacy shall be
equal to the reimbursement amount calculated on a per-unit basis
using the same generic product iden tifier or generic code number
paid to the PBM-owned or PBM-affiliated pharmacy;
4. Deny a pharmacy the opport unity to participate in any form
of pharmacy network at preferred participation status , whether in-
network, preferred, or otherwise, if the pharmacy is willing to
accept the terms and conditions that th e PBM has established for
other pharmacies as a condit ion of preferred network for
participation status in the network or networks of the pharmacy ’s
choice;
5. Deny, limit or termi nate a pharmacy’s contract based on
employment status of any employee who h as an active license to
dispense, despite probation st atus, with the State Board of
Pharmacy;
6. Retroactively deny or reduce reimbursement for a cove red
service claim after return ing a paid claim res ponse as part of the
adjudication of the claim, unless:
SB1860 HFLR Page 8
BOLD FACE denotes Committee Amendments. 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
a. the original claim was submitted fraudulently, or
b. to correct errors identified in an audit, so long as
the audit was conducted in compliance wit h Sections
356.2 and 356.3 of Title 59 of the Okla homa Statutes;
or
7. Fail to make any payment due to a pharmacy or pharmacist for
covered services properly rendered in the event a PBM terminates a
pharmacy or pharmacist from a pharmacy benefits manager network.
C. The prohibitions under this section s hall apply to contracts
between pharmacy benefits manag ers and pharmacists or pharmacies
providers for participation in retail pharmacy networks.
1. A PBM provider contract shall not prohibit, restrict , or
penalize a pharmacy or pharmac ist in any way for d isclosing to an
individual any health care information that the pharmacy or
pharmacist deems appropriate reg arding:
a. not restrict, directly or indirectly, any pharmacy
that dispenses a prescription drug f rom informing, or
penalize such pharmacy for infor ming, an individual of
any differential between the in dividual’s out-of-
pocket cost or coverage with respect to acquisition of
the drug and the amount an individual would pay to
purchase the drug directly the nature of treatment,
risks, or alternatives to t he prescription drug being
dispensed, and
SB1860 HFLR Page 9
BOLD FACE denotes Committee Amendments. 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
b. ensure that any entity that provides pharmacy benefits
management services under a contract with any such
health plan or health insurance coverage does not,
with respect to such plan or cover age, restrict,
directly or indirectly, a pharmacy that dispenses a
prescription drug from informing, or penalize such
pharmacy for informing, a covered individual of any
differential between the individual ’s out-of-pocket
cost under the plan or coverage wi th respect to
acquisition of the drug and the amount an individual
would pay for acquisition of the drug without using
any health plan or health insurance coverage the
availability of alternate therapies, consultations , or
tests,
c. the decision of utilizat ion reviewers or sim ilar
persons to authorize or deny services, and
d. the process that is used to authorize or deny
healthcare services and struc tures used by the health
insurer.
2. Provider contracts shall not prohibit a ph armacy or
pharmacist from disc ussing information r egarding the total cost of
pharmacist services for a prescription drug or from selling a more
affordable alternative to the co vered person if such alternative is
available.
SB1860 HFLR Page 10
BOLD FACE denotes Committee Amendments. 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
A pharmacy benefits manager ’s contract with a participating
pharmacist or pharmacy 3. Provider contracts shall not prohibit,
restrict or limit disclosure of information to the Insurance
Commissioner, law enfo rcement or state and federal governmental
officials investigating or examining a complaint or conducting a
review of a pharmacy be nefits manager’s compliance with the
requirements under the Patient’s Right to Pharmacy Choice Act.
3. 4. A pharmacy benefits manager shall establish and maintain
an electronic claim inquiry processing sys tem using the National
Council for Prescription Drug Programs’ current standards to
communicate information to pharmacies submitting claim inquiries.
SECTION 4. AMENDATORY 36 O.S. 2021, Section 6963, is
amended to read as follows:
Section 6963. A. A hea lth insurer shall be respon sible for
monitoring all activities carried out by, or on behalf of, the
health insurer under the Patient ’s Right to Pharmacy Choice Act, and
for ensuring that all requirements of this act Section 6958 et seq.
of this title are met.
B. Whenever a health insurer performs pharmacy benefits
management on its own behalf or contracts with another person or
entity to perform activities required under this act pharmacy
benefits management, the health insurer shall be responsible for
monitoring the activities and conduct of that person or entity with
SB1860 HFLR Page 11
BOLD FACE denotes Committee Amendments. 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
whom the health insurer contracts and for ensuring that the
requirements of this act Section 6958 et seq. of this title are met.
C. An individual may be notifi ed at the point of sale when the
cash price for the purchase of a prescription d rug is less than the
individual’s copayment or coinsurance price for the purchase of the
same prescription drug.
D. A health insurer or pharmacy benefits manager (PBM) shall
not restrict an individual’s choice of in-network provider for
prescription drugs.
E. 1. An individual’s A patient’s choice of in-network
provider may include a retail an in-network pharmacy or a, whether
that pharmacy is in a preferred or nonpreferred ne twork, a retailer
pharmacy, mail-order pharmacy, or any other pharmacy . A health
insurer or PBM shall not r estrict such a patient’s choice of in-
network pharmacy providers. Such A health insurer or PBM shall not
require or incentivize using individuals by:
a. using any discounts in cost-sharing or a reduction in
copay, or the number of copays, or any other patie nt-
copay equivalent to individuals to receive
prescription drugs from an individual’s choice of in-
network pharmacy, or
b. using financial incentiv es to differentiate between
in-network pharmacies, whether that pharmacy is in a
SB1860 HFLR Page 12
BOLD FACE denotes Committee Amendments. 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
preferred or nonpreferred network, a retail pharmacy,
mail order pharmacy, or any other type of pharmacy.
2. Nothing in this subsection shall be construed to prohibit a
person or entity participating in pharmacy benefits m anagement
activities from directing a patient to use a specific pharmacy for
the purchase of a specialty drug as de fined in paragraph 8 of
Section 1 of this act in the event the patient’s chosen in-network
pharmacy is unable to purchase and dispense the specialty drug.
F. A health insurer, pha rmacy or PBM shall adh ere to all
Oklahoma laws, statutes and rules when mail ing, shipping and/or
causing to be mailed or shipped prescription drugs into the State of
Oklahoma this state.
SECTION 5. REPEALER 36 O.S. 2021, Section 6964, is
hereby repealed.
SECTION 6. This act shall become eff ective November 1, 202 2.
COMMITTEE REPORT BY: COMMITTEE ON PUBLIC HEALTH, dated 04/06/2022 -
DO PASS, As Coauthored.